Amanote Research

Amanote Research

    RegisterSign In

How I Treat Waldenström's Macroglobulinemia

Blood - United States
doi 10.1182/blood.2019000725
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryImmunologyCell BiologyHematology
Date

December 5, 2019

Authors
Meletios A. DimopoulosEfstathios Kastritis
Publisher

American Society of Hematology


Related search

Atacicept in Relapsed/Refractory Multiple Myeloma or Active Waldenström's Macroglobulinemia: A Phase I Study

British Journal of Cancer
Cancer ResearchOncology
2009English

The Neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUS

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

The Gastrointestinal Tract, an Infrequent Target for Waldenström's Macroglobulinemia

Endoscopy
Gastroenterology
2010English

Prognostic Factors and Indications for Treatment of Waldenström's Macroglobulinemia

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2016English

How I Treat Primary Haemophagocytic Lymphohistiocytosis

British Journal of Haematology
Hematology
2018English

How I Treat Heparin-Induced Thrombocytopenia

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Waldenström's Macroglobulinemia in a 10-Year Stable IgG Monoclonal Gammopathy of Undetermined Significance

Leukemia Research
Cancer ResearchOncologyHematology
2009English

How I Treat Cancer-Associated Thrombosis

ESMO Open
Cancer ResearchOncology
2020English

How I Treat Cancers of Unknown Primary

ESMO Open
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy